Effect of Perioperative Dexmedetomidine Administration on Outcome in Cardiac Surgery Patients

Moscow Regional Research and Clinical Institute (MONIKI)

Status and phase: Completed; Phase 4

Conditions: Patient Outcome Assessment

Treatments: Drug: Dexmedetomidine

Study type: Interventional

Funder types: Other

Identifiers

NCT03091166

PD-CS-2016

Details and patient eligibility

About

Investigation of effect of perioperative Dexmedetomedine administration on mortality, length of ICU and hospital stay, delirium onset, major adverse cardiac and cerebrovascular events, acute kidney injury in cardiac surgery patients.

Enrollment: 169 patients

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Written informed agreement
• Elective surgery
• Use of CPB

Exclusion criteria

• Previous prolonged immobilization
• Reoperation

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

169 participants in 2 patient groups

Dexmedetomidine

Active Comparator group

Treatment:

Drug: Dexmedetomidine

No Dexmedetomidine

No Intervention group